January 24, 2023
The power of dual immunotherapy >
December 12, 2022
Biking the globe for C2C4C >
New Approaches to Multiple Myeloma
December 09, 2022
Our bold vision for multiple myeloma >
November 17, 2022
Exploring multiple paths to advance BCMA-targeted therapies >
A beacon of hope
October 25, 2022
A beacon of hope >
Group of Cyclists Riding Through Rain
July 28, 2022
C2C4C: Back on the road and bigger than ever >
Today’s cell therapy insights shaping tomorrow
July 20, 2022
Today’s cell therapy insights shaping tomorrow >
abder schoenfeld
May 17, 2022
The evolution of lung cancer research >
Healthcare professionals
March 31, 2022
The quest to stop cancer from coming back  >
Lata Jayaraman, head of Oncology Drug Discovery
January 20, 2022
Catching a Tumor: Highlighting Bristol Myers Squibb’s commitment to facing the challenge of cancer resistance >
December 08, 2021
The potential of our pipeline >
Samit Hirawat, M.D., Executive Vice President, Chief Medical Officer, Global Drug Development, Bristol Myers Squibb
November 10, 2021
The future of cancer care: transformative innovation for all >